News
AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Artificial ...
3d
News-Medical.Net on MSNNew nanobody-liposome combo stops lung cancer growth and delivers targeted chemotherapyResearchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...
While cancer-associated fibroblasts (CAFs) significantly influence tumor progression, their temporal dynamics remain poorly understood. We investigated time-dependent interactions between non-small ...
The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.
22h
Vietnam Investment Review on MSNNature Medicine Publishes Innovent’s Promising Phase 1 Gastric Cancer DataIntegrated pharmacokinetics (PK), exposure-response, safety, and efficacy data supported 6 mg/kg Q3W as the recommended Phase 2 dose (RP2D) of IBI343. This provides support for the conduct of ...
The European Commission (EC) has approved BeOne Medicines’ Tevimbra (tislelizumab) as part of a first-line combination ...
This newly launched program can save lives, with the proportion of cases identified at an early stage expected to rise from ...
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results